These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J7512

  Prednisone, immediate release or delayed release, oral, 1 mg

• J7513

  Daclizumab, parenteral, 25 mg

• J7514

  Mycophenolate mofetil (myhibbin), oral suspension, 100 mg

• J7515

  Cyclosporine, oral, 25 mg

• J7516

  Injection, cyclosporine, 250 mg

• J7517

  Mycophenolate mofetil, oral, 250 mg

• J7518

  Mycophenolic acid, oral, 180 mg

• J7519

  Injection, mycophenolate mofetil, 10 mg

• J7520

  Sirolimus, oral, 1 mg

• J7521

  Tacrolimus, granules, oral suspension, 0.1 mg

• J7525

  Tacrolimus, parenteral, 5 mg

• J7527

  Everolimus, oral, 0.25 mg

• J7528

  Mycophenolate mofetil, for suspension, oral, 100 mg

• J7599

  Immunosuppressive drug, not otherwise classified

• J7601

  Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg

• J7604

  Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram

• J7605

  Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms

• J7606

  Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms

• J7607

  Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg

• J7608

  Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram

• J7609

  Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg

• J7610

  Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg

• J7611

  Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg

• J7612

  Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg

• J7613

  Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg

• J7614

  Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg

• J7615

  Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg

• J7620

  Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme

• J7622

  Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

• J7624

  Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

• J7626

  Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg

• J7627

  Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg

• J7628

  Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

• J7629

  Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

• J7631

  Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams

• J7632

  Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams

• J7633

  Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram

• J7634

  Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram

• J7635

  Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

• J7636

  Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

• J7637

  Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

• J7638

  Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

• J7639

  Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

• J7640

  Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms

• J7641

  Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram

• J7642

  Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

• J7643

  Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

• J7644

  Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

• J7645

  Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

• J7647

  Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/22/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.